Evidence atlas · Topic

Rehabilitationwhat the research examines

Short answer: The library holds 27 references on virtual reality and rehabilitation, published between 2003 and 2026. They include 14 systematic reviews or meta-analyses and 2 randomised controlled trials. The research mainly examines recovery of the upper limb and of motor function after a stroke.

The evidence in numbers

27References
14Systematic reviews and meta-analyses
2Randomised trials
2003–2026Years
  • Meta-analyses8
  • Systematic reviews6
  • Randomised controlled trials2
  • Pilot or feasibility studies2
  • Qualitative or user studies2
  • Narrative or scoping reviews3
  • Essays, editorials or conceptual papers1
  • Books or chapters1
  • Clinical studies, design not stated2

Counted in the RVer study library · languages: Portuguese, English. The design of each study was classified by the team from the publication.

What the research examines

  • Recovery of the upper limb and of motor function after a stroke.
  • Balance, gait and fall risk, particularly in Parkinson's disease.
  • Physical exercise and cognition in older people.
  • Whether the programmes are acceptable and easy to use for physiotherapists and patients.

What is not yet known

  • The right dose: duration, frequency and intensity of the sessions.
  • Whether gains carry over to everyday activities, and whether they last.
  • Differences between immersive (headset) and non-immersive (screen) virtual reality.

The references, by study design

Meta-analyses · 8

Randomised controlled trials · 2

Pilot or feasibility studies · 2

Qualitative or user studies · 2

Narrative or scoping reviews · 3

Essays, editorials or conceptual papers · 1

Books or chapters · 1

Clinical studies, design not stated · 2

Glossary terms

Other topics

This page describes what published research on virtual reality examines in this topic. It is not a claim about RVer's performance and does not replace clinical assessment. The Class I medical device registration (EUDAMED, Basic UDI-DI 56006195127RVERTZ, and INFARMED, Portugal, CDM 94571546) covers the RVer base product.